Frontlight ResearchEarly access
Taking people in United StatesPhase 2
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
Key facts
- Who runs it
- Stephen Robert Marder
- Where
- Los Angeles, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 40 people, planned
- Started
- 1 Mar 2025
- Expected to end
- 1 Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 3,4-methylenedioxymethamphetamine
- d-amphetamine
- Therapy
- Record updated
- 19 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- At Screening, meet DSM-5 criteria for current PTSD with a symptom duration of at least 6 months
- Fluent in speaking and reading the predominantly used or recognized language of the study site (English)
- Must be a veteran enrolled at a VA Healthcare Center in the Greater Los Angeles area
- Able to swallow pills
- Agree to have study visits audiovisually recorded, including Experimental Sessions, IR assessments, and non-drug therapy sessions
- Able to provide a contact (relative, spouse, close friend, or other support person) who is willing and able to be reached by the investigators in the event of the participant becoming unwell or unreachable
- Able to identify appropriate support person(s) to stay with the participant on the evenings of Experimental Sessions if needed
- May have well-controlled hypertension that has been successfully treated with anti-hypertensive medicines, if they pass additional screening to rule out underlying cardiovascular disease
- May have asymptomatic Hepatitis C virus (HCV) that has previously undergone evaluation and treatment as needed
- Body weight of at least 45 kilograms (kg). Participants with a body weight of 45-48 kg must also have a body mass index (BMI) within the range of 18 to 30 kg/m2. BMI must be within 18 to 32 kg/m2 (inclusive)
- A person able to be pregnant (PABP) must use a highly effective contraceptive method
Who cannot take part
- Are abusing illegal drugs
- Have evidence or history of significant medical or psychiatric disorders
- Unable or unwilling to safely taper off prohibited psychiatric medication
- Are not able to give adequate informed consent
- Current enrollment in any other clinical study involving an investigational study treatment or any other type of medical research, unless approved by the study clinician
This trial is currently available in United States.
- VA Greater Los Angeles Healthcare System, Westwood campusLos Angeles, United StatesContact: Stephanie L Taylor, PhD (principal investigator)Not yet recruiting
- West Los Angeles Veteran AffairsLos Angeles, United StatesContact: Gerard DeVera, BATaking people
About the trial
What the trial wants to find out
This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years and older with PTSD of at least moderate severity.
The 2 groups in the trial
- MDMA-Assisted TherapyTreatment being tested
Participants will receive a flexible divided-dose of MDMA plus therapy at Experimental Sessions.
Treatment: 3,4-methylenedioxymethamphetamine and Therapy
- Low Dose D-Amphetamine Assisted TherapyExisting treatment, for comparison
Participants will receive a flexible divided dose plus therapy at Experimental Sessions.
Treatment: d-amphetamine and Therapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Double-Blind, Single-Site Phase II 2-Arm Study to Compare the Safety and Preliminary Efficacy of Manualized MDMA-Assisted Therapy to Low Dose D-Amphetamine Assisted Therapy in Veterans For The Treatment of Moderate to Severe PTSD
- Record updated
- 19 August 2026